1. 321 Cancer risk with topical pimecrolimus and tacrolimus for atopic dermatitis: systematic review and Bayesian meta-analysis. (25th January 2023) Authors: Chu, Alexandro W L; Devasenapathy, Niveditha; Wong, Melanie; Srivastava, Archita; Ceccacci, Renata; Lin, Clement; MacDonald, Margaret; Wen, Aaron; Steen, Jeremy; Levine, Mitchell; Pyne, Lonnie; Wang, Julie; Spergel, Jonathan M; Silverberg, Jonathan I; Ong, Peck Y; O'Brien, Monica; Martin, Stephan... Journal: British journal of dermatology Issue: Volume 188(2023)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Cancer risk with topical calcineurin inhibitors, pimecrolimus and tacrolimus, for atopic dermatitis: a systematic review and meta-analysis. (January 2023) Authors: Devasenapathy, Niveditha; Chu, Alexandro; Wong, Melanie; Srivastava, Archita; Ceccacci, Renata; Lin, Clement; MacDonald, Margaret; Wen, Aaron; Steen, Jeremy; Levine, Mitchell; Pyne, Lonnie; Schneider, Lynda; Chu, Derek K; Asiniwasis, Rachel Netahe; Boguniewicz, Mark; Ceccacci, Renata; Chen, Lina;... Journal: Lancet Issue: Volume 7:Number 1(2023) Page Start: 13 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Pharmacological prevention of fractures in patients undergoing glucocorticoid therapies: a systematic review and network meta-analysis. (23rd June 2020) Authors: Deng, Jiawen; Silver, Zachary; Huang, Emma; Zheng, Elena; Kavanagh, Kyra; Wen, Aaron; Cheng, Wei; Dobransky, Johanna; Sanger, Stephanie; Grammatopoulos, George Journal: Rheumatology Issue: Volume 60:Number 2(2021) Page Start: 649 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗